Cornelis Erik Hack,Cafer Yildiz,Louis Boon,Petrus Johannes Simons
申请号：
US14892850
公开号：
US09944717B2
申请日:
2014.05.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to means and methods that relate to binding molecules that bind human complement factor C2. Specific binding molecules are described with specific C2 activity inhibiting properties. Such binding molecules are useful in the treatment of symptoms of various human diseases among which there is inflammatory disease, neuro-inflammatory disease or ischemia-reperfusion (I/R) injury. Disease.
